Skip to main content
. 2018 Mar 18;12(2):92–98. doi: 10.22074/ijfs.2018.5232

Table 3.

Oral antihypertensive drugs commonly used in pregnancy


Drug Indication FDA category Initial dose Maximum dose Potential side effects

Methyldopa Often used as first line B 125-250 mg BD 500 mg QID Lethargy
Labetalol Often used as first line C 100 mg BD 200-400 mg QID Exacerbation of asthma
Nifedipine (immediate release) Second line or alternative first line C 10-20 mg BD 40 mg BD Concern for synergy with magnesium sulfate for neuromuscular depression

Modified from: Queensland Clinical Guideline: Hypertensive disorders of pregnancy (23) and Chronic Hypertension in Pregnancy (16). Category B; Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women, Category C; Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks, BD; Twice a day, and QID; Four times a day.